A detailed history of Xtx Topco LTD transactions in Hille Vax, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 42,753 shares of HLVX stock, worth $89,353. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,753
Previous 24,491 74.57%
Holding current value
$89,353
Previous $35,000 142.86%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

BUY
$1.39 - $2.04 $25,384 - $37,254
18,262 Added 74.57%
42,753 $85,000
Q1 2025

May 07, 2025

BUY
$1.45 - $2.14 $35,511 - $52,410
24,491 New
24,491 $35,000

Others Institutions Holding HLVX

About HilleVax, Inc.


  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $69.9M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.